While Magnificent Seven drove equity index returns in recent years, earnings growth has been broadening beyond mega-cap tech ...
Chiesi Group (“Chiesi”), an international research-focused biopharmaceutical group and certified B Corp, and KalVista Pharmaceuticals, Inc. (“KalVista”) (Nasdaq: KALV), today announced that the ...
First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025Dupixent- global net sales (recorded by Sanofi) increased 33% to $4.9 billion EYLEA HD- U.S. net sales increased 52% ...
This news release constitutes a 'designated news release” for the purposes of the prospectus supplement dated November 19, 2025 to the short form base shelf prospectus of Brookfield Infrastructure ...
AFL.com.au's rolling list of the top players in the AFL is back, where we will rank the best of the best every month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results